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Giant tortoises 
make a comeback 
in Madagascar
Just two years after their 
reintroduction as part of a 
bold conservation strategy, 
giant tortoises (Aldabrachelys 
gigantea) have hatched in the 
wild in Madagascar for the 
first time in around 600 years. 
This milestone in rewilding 
could provide insight into 
the structure and dynamics 
of Madagascar’s unique 
ecosystems, which were shaped 
by megafauna extirpated 
centuries ago. For us, some of 
the conservation biologists 
involved, it feels like a time-
travel bonanza.
Overexploited and driven 
to extinction in Madagascar 
after humans arrived on the 
island 1,500 years or so ago 
(see B. E. Crowley Quat. Sci. Rev. 
29, 2591–2603; 2010), giant 
tortoises survived because they 
colonized remote islands in the 
Seychelles. With the support of 
the Madagascan government, 
12 were released in 2018 
into a secure nature reserve. 
Two hatchlings appeared there 
in 2019, followed by another 
25 in October this year. Now in a 
nursery, these juveniles will be 
returned to the wild once their 
carapaces can protect them 
from predators.
This type of innovative 
approach could help stop 
the catastrophic decline in 
the island’s biodiversity, 
particularly in a changing 
climate (see also B. B. N. 
Strassburg et al. Nature 586, 
724–729; 2020).
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COVID-19: students 
caught in Pakistan’s 
digital divide
Education in developing 
countries with patchy Internet 
coverage is particularly hard-
hit by the COVID-19 pandemic 
(see Nature 585, 482; 2020), 
compromising the future of 
students unable to access online 
teaching. A United Nations’ 
resolution emphasizes access 
to the Internet as a means of 
bridging the digital divide and 
facilitating the fundamental 
human right to education 
(see go.nature.com/2kcjp1p). 
In Pakistan, for example, 
nationwide Internet availability 
must be accelerated if the 
country’s potential is not to be 
irreversibly compromised.
Take the remote mountainous 
Gilgit-Baltistan region, which 
has a record of high literacy. This 
will plummet without proper 
Internet connectivity because 
local schools can no longer 
teach. University students 
returning home in lockdown 
cannot access their institutional 
online classes.
In December 2019, the 
government started the 
Digital Pakistan initiative 
(DPI) to prioritize “access and 
connectivity”. After a year, an 
unacceptable proportion of 
the population is still without 
electricity, let alone broadband. 
A further blow to Pakistan’s 
education and research has 
been dealt by the government’s 
continual axing of the country’s 
Higher Education Commission 
(HEC) budget.
As a researcher from Pakistan, 
I urge the government and the 
leadership of the DPI and the HEC 
to speed up plans to rectify this 
digital divide so that education 
can flourish again (see also 
Nature 582, 162–164; 2020).






Panama has gone one step 
further than other Latin 
American countries that 
use the unproven drug 
ivermectin against COVID-19 
(see Nature 586, 481–482; 
2020). The government 
has approved this drug and 
hydroxychloroquine — despite 
the lack of efficacy data for 
either — and is stockpiling both. 
We find this alarming because 
the drugs’ side effects could be 
toxic in a significant proportion 
of the population.
In March 2020, 
hydroxychloroquine was 
prescribed only to people with 
COVID-19 who were taking 
part in a clinical-trial protocol. 
Panama’s ministry of health 
followed the advice of its 
Scientific Advisory Committee 
and two months later suspended 
the trial on the basis of 
growing evidence of the drug’s 
ineffectiveness (see M. R. Mehra 
et al. Lancet 395, 1820; 2020). 
The World Health Organization 
subsequently declared that, 
according to the available data, 
hydroxychloroquine does 
not reduce fatality in people 
hospitalized with COVID-19, nor 
does it ameliorate symptoms of 
mild or moderate illness.
Despite these developments, 
Panama has since purchased 
2,900,000 doses of 
hydroxychloroquine and 
450,000 doses of ivermectin, 
to be distributed as part of a 
self-treatment kit to people self-
isolating with the virus.
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Explain ESA’s late 
ditching of new 
space telescope
The European Space Agency 
(ESA) has cancelled its proposed 
Space Infrared Telescope for 
Cosmology and Astrophysics 
(SPICA; go.nature.com/2jfp8fw) 
just months before the final 
mission-selection review. 
The decision — made by the 
executive on the grounds 
of undisclosed costs, not 
by the Science Programme 
Committee on the basis of 
peer review — has left many 
in the astronomy community 
with no confidence in the 
decision-making processes 
at the agency’s highest levels 
(see public letter to ESA’s 
director of science signed 
by almost 300 scientists, at 
https://spicarebelalliance.com).
ESA member states and 
collaborating countries have 
invested heavily in developing 
SPICA and expected a fair, 
transparent process for all 
competing projects. This 
cancellation was imposed 
without negotiation or 
communication with the SPICA 
team, and no details were given 
about the underlying costings. 
Why these suddenly became a 
problem after the completion of 
several comprehensive reviews 
is a mystery. The project team 
was given no opportunity to find 
a solution.
Without transparency and 
accountability in the making 
of such decisions, nothing will 
prevent other ESA projects from 
experiencing a similar fate.
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